Resource centre

Main menu

59 results

Adaptive sampling

Workflow
Workflow overview: pharmacogenomics with adaptive sampling
August 5 2025
Workflow
Workflow overview: Hereditary Cancer Panel
January 20 2026
Webinar
Transforming hereditary cancer sequencing with adaptive sampling target enrichment
November 11 2025
Knowledge exchange
Adaptive sampling explained: the future of flexible target enrichment
September 23 2025
Publication
Ultra-long sequencing for contiguous haplotype resolution of the human immunoglobulin heavy chain locus
December 17 2024
Publication
Ultra-fast sample-to-sequencing workflow for clinical diagnostics using micropillars
January 30 2026
Publication
The utility of long-read sequencing in diagnosing early-onset Parkinson's disease
December 19 2024
Publication
Targeted sequencing and iterative assembly of near-complete genomes
November 24 2025
Publication
Targeted adaptive sampling enables clinical pharmacogenomics testing and genome-wide genotyping
May 7 2025
Case study
Case study: solving the parent-of-origin effect in retinoblastoma to determine disease severity
April 4 2025
Publication
Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling
October 3 2025
Publication
ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumour
May 20 2025
Publication
Resolving the full set of human polymorphic inversions and other complex variants from ultra-long read data
May 29 2025
Publication
Resolving RH and GYP hybrid alleles while accessing the entire blood group genome with nanopore adaptive sampling
June 11 2025
Publication
Research focus: pharmacogenomics
March 11 2025
Video
Real-time genomic characterization of pediatric acute leukemia using adaptive sampling
May 24 2024
Publication
Real-time genomic characterisation of paediatric acute leukaemia using adaptive sampling
March 24 2025
Video
Rapid nephrogenomics for thrombotic microangiopathies
May 24 2024
Publication
Proof-of-principle: Nanopore adaptive sampling enables full blood group genome analysis and resolution of hybrid alleles
November 10 2025
Publication
Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma
December 26 2024

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

About Oxford Nanopore

© 2008 - 2026 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, AmPORE-TB, EPI2ME, GridION, MinION, MinKNOW, PromethION, P2 Solo, and P2 are registered trademarks or the subject of trademark applications of Oxford Nanopore Technologies plc in various countries. Information contained herein may be protected by copyright, patents or patents pending of Oxford Nanopore Technologies plc. All other brands and names contained are the property of their respective owners. Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in‐vitro diagnostic devices in some jurisdictions, please check individual product labelling.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Focus areas

Resource Centre

Workflow overview: pharmacogenomics with adaptive sampling

Workflow overview: Hereditary Cancer Panel

Transforming hereditary cancer sequencing with adaptive sampling target enrichment

Adaptive sampling explained: the future of flexible target enrichment

Ultra-long sequencing for contiguous haplotype resolution of the human immunoglobulin heavy chain locus

Ultra-fast sample-to-sequencing workflow for clinical diagnostics using micropillars

The utility of long-read sequencing in diagnosing early-onset Parkinson's disease

Targeted sequencing and iterative assembly of near-complete genomes

Targeted adaptive sampling enables clinical pharmacogenomics testing and genome-wide genotyping

Case study: solving the parent-of-origin effect in retinoblastoma to determine disease severity

Single-workflow nanopore whole-genome sequencing with adaptive sampling for accelerated and comprehensive paediatric cancer profiling

ROBIN: A unified nanopore-based assay integrating intraoperative methylome classification and next-day comprehensive profiling for ultra-rapid tumour

Resolving the full set of human polymorphic inversions and other complex variants from ultra-long read data

Resolving RH and GYP hybrid alleles while accessing the entire blood group genome with nanopore adaptive sampling

Research focus: pharmacogenomics

Real-time genomic characterization of pediatric acute leukemia using adaptive sampling

Real-time genomic characterisation of paediatric acute leukaemia using adaptive sampling

Rapid nephrogenomics for thrombotic microangiopathies

Proof-of-principle: Nanopore adaptive sampling enables full blood group genome analysis and resolution of hybrid alleles

Prognostic importance of direct assignment of parent-of-origin via long-read genome and epigenome sequencing in retinoblastoma

shared.filter

Products

Research areas

Techniques